U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Links from MedGen

Items: 43

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr2:47643435
GRCh38:
Chr2:47416296
MSH2G249C, G315CMismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome,
Hereditary nonpolyposis colorectal neoplasms
Uncertain significance
(Mar 15, 2022)
criteria provided, multiple submitters, no conflicts
2.
GRCh37:
Chr2:47637507-47637508
GRCh38:
Chr2:47410368-47410369
MSH2R148fs, R214fsMismatch repair cancer syndrome 2, Hereditary nonpolyposis colorectal neoplasmsPathogenic/Likely pathogenic
(Jan 3, 2023)
criteria provided, multiple submitters, no conflicts
3.
GRCh37:
Chr2:47698130
GRCh38:
Chr2:47470991
MSH2Y497C, Y563CHereditary nonpolyposis colorectal neoplasms, Muir-Torré syndrome, Lynch syndrome 1,
Mismatch repair cancer syndrome 2, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Aug 10, 2022)
criteria provided, conflicting interpretations
4.
GRCh37:
Chr2:47703565
GRCh38:
Chr2:47476426
MSH2A623T, A689THereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1,
Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms
Conflicting interpretations of pathogenicity
(Mar 20, 2023)
criteria provided, conflicting interpretations
5.
GRCh37:
Chr2:47693958
GRCh38:
Chr2:47466819
MSH2Hereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1, Mismatch repair cancer syndrome 2,
Muir-Torré syndrome, Hereditary cancer-predisposing syndrome, not specified
Likely benign
(Oct 7, 2022)
criteria provided, multiple submitters, no conflicts
6.
GRCh37:
Chr2:47690237
GRCh38:
Chr2:47463098
MSH2M485T, M419THereditary cancer-predisposing syndrome, Lynch syndrome 1, Mismatch repair cancer syndrome 2,
Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms
Conflicting interpretations of pathogenicity
(Mar 29, 2022)
criteria provided, conflicting interpretations
7.
GRCh37:
Chr2:47693947
GRCh38:
Chr2:47466808
MSH2S554N, S488NLynch syndrome 1, Mismatch repair cancer syndrome 2, Muir-Torré syndrome,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, Lynch syndrome 1
Pathogenic/Likely pathogenic
(Aug 20, 2022)
criteria provided, multiple submitters, no conflicts
8.
GRCh37:
Chr2:47643484
GRCh38:
Chr2:47416345
MSH2N331S, N265SHereditary nonpolyposis colorectal neoplasms, Lynch syndrome, Hereditary cancer-predisposing syndrome,
not specified, Lynch syndrome 1, Muir-Torré syndrome,
Mismatch repair cancer syndrome 2
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
9.
GRCh37:
Chr2:47702296
GRCh38:
Chr2:47475157
MSH2R631K, R565KHereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1,
Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms, not provided
Conflicting interpretations of pathogenicity
(May 25, 2023)
criteria provided, conflicting interpretations
10.
GRCh37:
Chr2:47672764
GRCh38:
Chr2:47445625
MSH2E452K, E386KHereditary cancer-predisposing syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1,
Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms
Conflicting interpretations of pathogenicity
(Nov 1, 2022)
criteria provided, conflicting interpretations
11.
GRCh37:
Chr2:47630206-47656880
GRCh38:
Chr2:47403067-47429741
MSH2Lynch syndromePathogenic
(Jan 15, 2017)
criteria provided, single submitter
12.
GRCh37:
Chr2:47690263
GRCh38:
Chr2:47463124
MSH2S494P, S428Pnot provided, Mismatch repair cancer syndrome 2, Lynch syndrome 1,
Muir-Torré syndrome, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome
Conflicting interpretations of pathogenicity
(Feb 1, 2023)
criteria provided, conflicting interpretations
13.
GRCh37:
Chr2:47705460
GRCh38:
Chr2:47478321
MSH2T754S, T688SMismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided,
not specified
Conflicting interpretations of pathogenicity
(Sep 27, 2022)
criteria provided, conflicting interpretations
14.
GRCh37:
Chr2:47637374
GRCh38:
Chr2:47410235
MSH2Q170E, Q104Enot specified, Lynch syndrome 1, Lynch syndrome 1,
Muir-Torré syndrome, Mismatch repair cancer syndrome 2, Hereditary nonpolyposis colorectal neoplasms,
Hereditary cancer-predisposing syndrome, not provided
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
15.
GRCh37:
Chr2:47705460
GRCh38:
Chr2:47478321
MSH2T754A, T688AMismatch repair cancer syndrome 2, Lynch syndrome 1, Muir-Torré syndrome,
Hereditary cancer-predisposing syndrome, Hereditary nonpolyposis colorectal neoplasms, not provided,
Lynch syndrome 1
Conflicting interpretations of pathogenicity
(Mar 30, 2023)
criteria provided, conflicting interpretations
16.
GRCh37:
Chr2:47630403
GRCh38:
Chr2:47403264
MSH2G25CMuir-Torré syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not provided
Uncertain significance
(Jun 7, 2023)
criteria provided, multiple submitters, no conflicts
17.
GRCh37:
Chr2:47630150
GRCh38:
Chr2:47403011
MSH2Lynch syndrome, Muir-Torré syndrome, Mismatch repair cancer syndrome 2,
Lynch syndrome 1, Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome,
not provided, Lynch syndrome 1
Uncertain significance
(Apr 12, 2023)
criteria provided, multiple submitters, no conflicts
18.
GRCh37:
Chr2:47637432
GRCh38:
Chr2:47410293
MSH2A189G, A123GHereditary nonpolyposis colorectal neoplasms, Muir-Torré syndrome, Mismatch repair cancer syndrome 2,
Lynch syndrome 1, Hereditary cancer-predisposing syndrome, not specified,
not provided, Lynch syndrome 1
Conflicting interpretations of pathogenicity
(Jun 15, 2023)
criteria provided, conflicting interpretations
19.
GRCh37:
Chr2:47630496
GRCh38:
Chr2:47403357
MSH2E56KHereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1, Mismatch repair cancer syndrome 2,
Muir-Torré syndrome, Hereditary cancer-predisposing syndrome, not specified,
not provided
Conflicting interpretations of pathogenicity
(Aug 15, 2023)
criteria provided, conflicting interpretations
20.
GRCh37:
Chr2:47635548
GRCh38:
Chr2:47408409
MSH2N74H, N8HMismatch repair cancer syndrome 2, Muir-Torré syndrome, Lynch syndrome 1,
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome, not specified,
not provided, Lynch syndrome 1
Conflicting interpretations of pathogenicity
(Jun 15, 2023)
criteria provided, conflicting interpretations
21.
GRCh37:
Chr2:47637476
GRCh38:
Chr2:47410337
MSH2G204R, G138RMuir-Torré syndrome, Mismatch repair cancer syndrome 2, Lynch syndrome 1,
Hereditary cancer-predisposing syndrome, not provided, Hereditary nonpolyposis colorectal neoplasms,
Lynch syndrome 1
Conflicting interpretations of pathogenicity
(Mar 21, 2023)
criteria provided, conflicting interpretations
22.
GRCh37:
Chr2:47643483
GRCh38:
Chr2:47416344
MSH2N331D, N265DLynch syndrome 1Uncertain significance
(Jun 13, 2018)
reviewed by expert panel
23.
GRCh37:
Chr2:47630427
GRCh38:
Chr2:47403288
MSH2T33PHereditary nonpolyposis colorectal neoplasms, Lynch syndrome 1, Mismatch repair cancer syndrome 2,
Muir-Torré syndrome, Hereditary cancer-predisposing syndrome, not provided,
not specified, Lynch syndrome 1
Conflicting interpretations of pathogenicity
(Mar 21, 2023)
criteria provided, conflicting interpretations
24.
GRCh37:
Chr2:47637509
GRCh38:
Chr2:47410370
MSH2Q215*, Q149*Lynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
25.
GRCh37:
Chr2:47637371
GRCh38:
Chr2:47410232
MSH2I169V, I103VLynch syndromeLikely benign
(Sep 5, 2013)
reviewed by expert panel
26.
GRCh37:
Chr2:47635601-47635603
GRCh38:
Chr2:47408462-47408464
MSH2L94del, L28delLynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
27.
GRCh37:
Chr2:47630353
GRCh38:
Chr2:47403214
MSH2T8MLynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
28.
GRCh37:
Chr2:47703501
GRCh38:
Chr2:47476362
MSH2Mismatch repair cancer syndrome 2Pathogenic
(Feb 1, 2006)
no assertion criteria provided
29.
GRCh37:
Chr2:47630331
GRCh38:
Chr2:47403192
MSH2M1LLynch syndromeUncertain significance
(Jun 21, 2019)
reviewed by expert panel
30.
GRCh37:
Chr2:47702290
GRCh38:
Chr2:47475151
MSH2Q629R, Q563RLynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
31.
GRCh37:
Chr2:47698132
GRCh38:
Chr2:47470993
MSH2T564A, T498ALynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
32.
GRCh37:
Chr2:47698122
GRCh38:
Chr2:47470983
MSH2Lynch syndromeLikely benign
(Sep 5, 2013)
reviewed by expert panel
33.
GRCh37:
Chr2:47698103
GRCh38:
Chr2:47470964
MSH2Lynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
34.
GRCh37:
Chr2:47693948
GRCh38:
Chr2:47466809
MSH2Lynch syndromeLikely pathogenic
(Jun 21, 2019)
reviewed by expert panel
35.
GRCh37:
Chr2:47630468
GRCh38:
Chr2:47403329
MSH2H46QLynch syndromeLikely benign
(Dec 19, 2018)
reviewed by expert panel
36.
GRCh37:
Chr2:47657081
GRCh38:
Chr2:47429942
MSH2Lynch syndromeLikely pathogenic
(Jun 21, 2019)
reviewed by expert panel
37.
GRCh37:
Chr2:47657059
GRCh38:
Chr2:47429920
MSH2Q419K, Q353KLynch syndromeLikely benign
(Sep 5, 2013)
reviewed by expert panel
38.
GRCh37:
Chr2:47656969
GRCh38:
Chr2:47429830
MSH2R389*, R323*Lynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
39.
GRCh37:
Chr2:47637246
GRCh38:
Chr2:47410107
MSH2N127S, N61SLynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
40.
GRCh37:
Chr2:47703500
GRCh38:
Chr2:47476361
MSH2Lynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
41.
GRCh37:
Chr2:47698108
GRCh38:
Chr2:47470969
MSH2Lynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
42.
GRCh37:
Chr2:47693788
GRCh38:
Chr2:47466649
MSH2Lynch syndromeBenign
(Sep 5, 2013)
reviewed by expert panel
43.
GRCh37:
Chr2:47637317
GRCh38:
Chr2:47410178
MSH2M86fs, M152fsLynch syndromePathogenic
(Sep 5, 2013)
reviewed by expert panel
Format
Items per page
Sort by
Choose Destination